What's breaking now, across thousands of outlets.
For health plans: the real fix for rising IDR disputes starts before arbitration. See how 93% get resolved early.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.
Biological threat intelligence is increasingly becoming a workforce and business issue, not just a public health concern.
Fresh from its rebrand last week, Novo CEO Maziar Mike Doustdar spelled out on Monday the strategic vision that goes along with it. At the Danish drugmaker capital markets day in London ...
Luft anhalten, Kopfstand turnen, sich erschrecken lassen: Es gibt einiges, das Schluckauf in die Flucht schlagen soll. Experten erklären, wie das Hicksen entsteht, und was alle Tipps gemeinsam haben.
The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study.
When people stop taking antidepressants, they can feel terrible—their mood can plummet and anxiety can spike. But are these symptoms caused by withdrawal, or are they signs of a relapse?
Real-time data, analytics and collaboration can help Medicaid programs resolve issues earlier—without sacrificing participant choice.
